Healthcare IT News’ Bill Siwicki reports that Medical University of South Carolina (MUSC) has selected TriNetX for an electronic health record participant cohort assessment tool that enables research staff to tap into and leverage electronic health record (EHR) data, with a goal of honing in on a more focused targeting of prospective patients who may meet study criteria. MUSC has been in operations since 1824. MUSC is actively involved with clinical trials and provides links to a number of clinical trial initiatives including:
- SCresearch.org: The South Carolina Research Studies Directory designed specifically to help patients locate research studies in which to participate. It is browsable by topic, location and more.
- Hollings Cancer Center Clinical Trials
TriNetX is a technology-enabled global health research network that is selected to attempt to optimize clinical research and enable discoveries through the creation of real-world-evidence. It combines real-time access to longitudinal clinical data with state-of-the-art analytics to answer complex research questions in an expedited manner. It enables healthcare organizations, biopharmaceutical companies and contract research organizations (CROs) to collaborate, enhance trial design, improve site selection and planning, and bring new therapies to market faster. TriNetX combines real time access to longitudinal clinical data with state-of-the-art analytics to answer complex research questions at the speed of thought. The TriNetX platform is HIPAA and GDPR compliant. According to CrunchBase, they have raised $2.5 million since its inception in 2013. Based on TrialSite News initial research, it would appear TriNetX has grown at a healthy pace with little outside capital. It is securing a considerable amount of paying clients.